Skip to content

Dr Joachim Feldges

Partner

Munich

Feldges Joachim
Dr Joachim Feldges

Partner

Munich

Joachim is partner in our IP litigation practice and heads our German life sciences group. He is a dedicated patent litigation partner and has practised complex patent litigation since more than 30 years with a particular focus on pharmaceuticals, biotechnology and medical devices. 

He represents clients in infringement and validity cases before all major patent courts, the Federal Supreme Court and the Federal Patent Court and he has advised clients for many years developing and implementing international patent litigation strategies in numerous European jurisdictions. In addition, Joachim regularly represents clients in opposition proceedings before the European Patent Office. He also represents clients in arbitration proceedings and acts as an arbitrator and mediator according to the WIPO rules in IP disputes. 

Noteworthy experience includes advising:

  • A pharmaceutical company concerning the infringement of an SPC by a generic product for the treatment of epilepsy.
  • Pfizer against a parallel importer to prevent parallel imports of a medicinal product from the EU accession countries during the paediatric extension of a supplementary protection certificate including proceedings in front of the CJEU.An innovative company of genetically engineered food additives on license agreements regarding the CRISPR technology.
  • A company in a patent dispute on offshore windparks in both patent infringement and nullity proceedings with regard to the German part of a European Patent.
  • A company producing industrial machines in the automotive industry in infringement and nullity proceedings concerning a German Patent.
  • A manufacturer of mounting machines for electronic components in a multinational patent dispute.
  • A global pharmaceutical company in a dispute on a license agreement on a bispecific antibody.

News & insights

Trees

News: 14 APRIL 2021

Allen & Overy signs the Campaign for Greener Arbitrations: The Green Pledge

Allen & Overy is proud to have signed the Campaign for Greener Arbitrations: The Green Pledge, and in doing so formally commits its International Arbitration Group to reducing its environmental…

Read more
A&O advising on the creation of new Welsh mental health and substance misuse charity, Adferiad Recovery

News: 14 APRIL 2021

A&O advising on the creation of new Welsh mental health and substance misuse charity, Adferiad Recovery

A cross-practice team from Allen & Overy, working on a pro bono basis, is advising on the merger of four Welsh mental health and substance misuse charities and the creation of a new charity, Adferiad…

Read more
image of shopping bags in a female hand with high street in the background

Publications: 13 APRIL 2021

New explanations by the President of UOKiK regarding the imposition of penalties on undertakings

Please refer to our latest publication written by Rafał Petruczuk on the recently published explanations regarding how the President of the UOKiK determines fine amounts for violations of competition…

Read more
Exterior of modern buildings

Publications: 29 APRIL 2019

Practical preparations for Brexit: a global perspective

Only the very brave are predicting with certainty the outcome of attempts by the UK to leave the EU.

Read more

Office

Munich

Allen & Overy LLP
Maximilianstraße 35
80539 Munich

View office →

Qualifications

Professional

Admitted as German Rechtsanwalt, 1987

Academic

Docteur en droit, University of Geneva, Switzerland, 1987
Diplôme d’Etudes Supérieures en Droit, University of Geneva, Switzerland, 1984


Pro-bono experience

  • Joachim is since 2018 a curator for Amref Health Africa Germany and acted as an ambassador in A&O’s global charity partnership with Amref in 2014-2016.

Recognition

Published work

  • Feldges J. (2017) Handbuch des Medizinprodukterechts, 2nd Edition
  • Feldges J., Kramer B. (2011) “Intellectual Property in the Life Sciences”, Germany, pp. 193 
  • Feldges J. (2011) „Anmerkung zum Urteil des EuGH vom 18.10.2011 C-34/10 – Brüstle/Greenpeace“, GRUR 2011, pp. 1045 
  • Feldges J, Kramer B. (2010) „Die Bestimmung des Schutzbereiches von ergänzenden Schutzzertifikaten für Arzneimittel“, Festschrift für Wolfgang von Meibom, pp. 57 
  • Feldges J. (2009) „Kann die Dosierung eines Medikamentes Grundlage einer patentfähigen Erfindung sein?“ Festschrift für Thomas Reimann, pp. 91 
  • Feldges J., Kramer B. (2009) “Patent Law, in Business Laws of Germany”, 2009 ed., p. 197-305. 
  • Feldges J. (2007) „Die Durchsetzung von Patenten in europäischen Streitigkeiten“, Festschrift für Tilman Schilling, pp. 111 
  • Feldges J., Kramer B. (2007) “Co-ownership of Patents under German Law, Journal of Intellectual Property Law & Practice”, pp. 742 
  • Kilger, Feldges, Jaenichen (2005) “The Erosion of Compound Protection In Germany”, Journal of the Patent and Trademark Office Society Vol. 87, pp. 569 
  • Feldges J. (2005) „Ende des absoluten Stoffschutzes? Zur Umsetzung der Biotechnologie-Richtlinie“, GRUR 2005, pp. 977 
  • Feldges J., Kanz C. (2003) in: Anhalt/Dieners, Handbuch des Medizinprodukterechts, § 25 Schutz von Medizinprodukten durch technische Schutzrechte, Munich